CEACAM5 and neoplasm: The discrepancy between affinity determined by surface plasmon resonance and cell binding is likely caused by a different epitope accessibility on cells and/or differences in the glycosylation profiles between recombinant NABA-CEACAM5 and CEACAM5 expressed on tumor cell surfaces.